A Randomized Control Trial of Hip Dislocation Techniques for Pediatric Patients With Cerebral Palsy

ORCHID: Osteotomy vs Resection in CP Hip for Irreducible Dislocations: A Randomized Controlled Trial Comparing McHale to Castle Techniques

This randomized controlled trial will compare proximal femoral resection-interposition arthroplasty to proximal femoral resection with subtrochanteric valgus osteotomy for the treatment of painful irreducible hip dislocation in patients with cerebral palsy. The primary outcome is quality of life and care giver burden measured by The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) score at one year. Secondary outcomes will include pain (NCCPC-R, PROMIS pain intensity and PROMIS pain interference), function (mobility questions), complications and surgical parameters such as OR time and fluoroscopy time. A cost-effectiveness analysis will follow completion of the randomized controlled trial (RCT). The authors hypothesize that mean CPCHILD scores (measured at 1 year) will be significantly higher following the Subtrochanteric Valgus Osteotomy technique compared to Proximal Femoral Resection-Interposition Arthroplasty technique. Furthermore, the Proximal Femoral Resection-Interposition Arthroplasty technique will have a shorter length of hospital stay, shorter fluoroscopy and OR times and the Subtrochanteric Valgus Osteotomy will have longer sitting tolerance, less pain, smaller burden for caregivers, better health, and higher quality of life. Additionally the authors hypothesize that Subtrochanteric Valgus Osteotomy will be more expensive than Proximal Femoral Resection-Interposition Arthroplasty, due to the cost of the plate, longer operative time, longer length of stay, and blood loss, but Subtrochanteric Valgus Osteotomy will be preferred by patients due to less pain and better functional and quality of life outcomes.The results of this study are expected to improve outcomes for children with cerebral palsy with painful irreducible dislocated hips.

Study Overview

Detailed Description

The treatment of children with cerebral palsy (CP) with painful dislocated hips is a clinical challenge for the pediatric orthopedic surgeon. Although current regimens are based primarily on hip surveillance and early treatment of subluxation to avoid progression to dislocation, hip dislocations are still identified in the CP population. In younger children, in whom the hip is still of relatively normal morphology with intact cartilage and potential for remodeling (often identified by open tri-radiate cartilage) open hip reduction, varus rotational osteotomy and pelvic osteotomy may be a reasonable option. In older children, those with a deformed or damaged femoral head, those with closed triradiate cartilage, or in those with an irreducible hip, salvage options must be considered.

Multiple techniques exist for treatment of irreducible painful hips in CP, including proximal femoral resection-interposition arthroplasty, resection at the femoral neck with subtrochanteric valgus osteotomy, hip replacement or hip arthrodesis (fusing the femur to the socket in a static position). This wide variation in practices is consistent with clinical uncertainty regarding the optimal treatment method for this problem. The most frequently performed intervention for a painful irreducible hip in the setting of CP is a form of resection arthroplasty, either alone (proximal femoral resection-interposition arthroplasty) or in conjunction with valgus support osteotomy. Technique selection is based on the functional level of the patient, patient symptoms, and surgeon preference.{{257 Van Riet,A. 2009; 253 Wright,P.B. 2013}}

Although outcomes of resection at the femoral neck with subtrochanteric valgus osteotomy and proximal femoral resection-interposition arthroplasty techniques exist, published reports are retrospective non-randomized small series, which may be at risk for selection bias, and do not adequately capture all of the outcomes of interest, depending on what data has been routinely collected and documented in the medical chart.{{253 Wright,P.B. 2013; 259 Leet,A.I. 2005}},{{252 Boldingh,E.J. 2013}} Furthermore, results from these studies may be influenced by confounding factors, such as differences in patient age and other inequalities between groups at the time of surgery.{{252 Boldingh,E.J. 2013; 253 Wright,P.B. 2013; 277 Settecerri,J.J. 2000}} To the investigators knowledge, no prospective randomized comparison of hip resection techniques has been published accurately assessing child and parent quality of life, hip migration, or taking into account sitting and standing tolerance, pain, or hospital length of stay. Operative measures such as surgical time, blood loss and radiation exposure from intra-operative fluoroscopy have not previously been compared in a prospective manner.

This study was designed as a multicenter randomized trial to answer an important clinical question about a rare condition, and to do so with a clearly defined objective and validated set of outcomes. This simple trial can be executed on a relatively small budget with simple outcome measures, and recruitment of a small number of patients at each of a few centers well equipped for research. By involving multiple surgeons and patients from various geographies, we improve the generalizability of this study. Our institution and collaborating institutions have been successful in completing randomized clinical trials in the past. This study will answer a clinical question that is important and current, providing orthopedic surgeons with an evidence-based answer: the optimal technique in treating painful irreducible hip dislocation in patients with cerebral palsy. The proposed research study aims to fill these gaps.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6H 3V4
        • British Columbia Children's Hospital
    • Ontario
      • Toronto, Ontario, Canada, M5G1X8
        • The Hospital for Sick Children
    • Arizona
      • Phoenix, Arizona, United States, 85016
        • Phoenix Children's Hospital
    • Florida
      • Miami, Florida, United States, 33155
        • Miami Children's Hospital
    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Boston Children's Hospital
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Children's Hospital of Michigan
    • New York
      • New York, New York, United States, 10021
        • Hospital for Special Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 7-21 years of age
  • Painful irreducible Hip dislocation and cerebral palsy diagnosis
  • GMFCS 4 or 5

Exclusion Criteria:

  • GMFCS 1-3
  • Decline to participate
  • Outcome scales not validated in patient language.
  • Candidate for total hip replacement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Proximal Femoral Resection Arthroplasty
A 10-12 cm direct lateral incision will be made distally from the greater trochanter. The abductors of the hip are detached with sharp dissection. A capsulotomy is performed. The femur is exposed in a supra-periosteal manner (2 cm distal to the lesser trochanter) at the level of the ischium; transverse osteotomy will then be performed. The joint capsule will be sutured to itself. The iliopsoas tendon and the abductor tendons are attached to the capsule. The quadriceps will be brought around the proximal femoral stump and sutured to medial tissues.
Drains will be placed at the surgeon's discretion. Patients will be placed in skin traction on the operative side. Post-operative bracing or casting will be at the surgeon's discretion. All patients will receive standardized post-operative prophylactic radiation to minimize heterotopic ossification.
Other Names:
  • Castle Technique
Experimental: Subtrochanteric Valgus Osteotomy
A 10-12 cm direct lateral incision will be made distally from the greater trochanter. The medial half of the abductors may be incised off the greater trochanter for repair. The femoral head is resected at the base of the neck. The ligamentum teres is incised off the head and preserved. A lateral closing wedge osteotomy is performed below the lesser trochanter. 3.5 or 4.5 5 hole locking/non-locking surgeon-contoured plate ( 45⁰) will be used to stabilize the osteotomy. Femoral torsion will be corrected. The psoas tendon will attach the ligamentum teres to the lesser trochanter. The anterior and posterior capsule is sutured together creating interposition tissue. If the ligamentum teres was sutured to the lesser trochanter, the capsule will not close, but will be covered by the psoas tendon.
Drains will be placed at the surgeon's discretion. Post-operative bracing or casting will be at the surgeon's discretion. All patients will receive standardized post-operative prophylactic radiation to minimize heterotopic ossification.
Other Names:
  • McHale Technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Quality of Life and Caregiver Burden
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Measured by CPCHILD.
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Hip Migration
Time Frame: Baseline, post-operative, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
X-rays measuring hip migration will be standardized to anteroposterior (AP) Pelvis and Frog lateral. Patient positioning will be standardized according to normal clinical practice.
Baseline, post-operative, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Pain Scores
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
NCCPC-R, PROMIS Pediatric Pain Interference, PROMIS Pediatric Pain Intensity
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Caregiver Burden
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Indirect Cost Form
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Length of Stay
Time Frame: An expected average of 5 days
Discharge date - admission date. Transform into number of days. Length of stay can vary from days to weeks, if serious complication occurs.
An expected average of 5 days
Sitting Tolerance
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Measured by wheelchair pressure mapping (hours /wk)
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Range of Motion
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Measured by goniometer (degrees)
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Complications
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Infection, deep vein thrombosis (DVT), fracture, heterotropic calcification
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Function
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Measured by GMFCS.
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Splint
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Need for splint or cast will be documented in medical records.
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Secondary Surgery
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Need for secondary surgery will be documented in medical records.
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Standing Tolerance
Time Frame: Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Measured by instander (hours/ week)
Baseline, 2-6 weeks, 5-7 months, 11-13 months and 23-25 months
Medical Costs
Time Frame: 4 years (end of study)
analyze claims data (approx 4 years)
4 years (end of study)
Operative Outcomes
Time Frame: intra-operative
radiation, total time during surgery, skin dose, blood loss, surgeon experience, hip resection technique
intra-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Actual)

May 13, 2021

Study Registration Dates

First Submitted

July 14, 2014

First Submitted That Met QC Criteria

October 7, 2014

First Posted (Estimate)

October 8, 2014

Study Record Updates

Last Update Posted (Actual)

May 17, 2021

Last Update Submitted That Met QC Criteria

May 13, 2021

Last Verified

May 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Proximal Femoral Resection Arthroplasty

3
Subscribe